Avermectins differentially affect ethanol intake and receptor function: Implications for developing new therapeutics for alcohol use disorders

International Journal of Neuropsychopharmacology

Volumn 17, Issue 6, 2014, Pages 907-916

  Asatryan, Liana ^a   Yardley, Megan M ^a   Khoja, Sheraz ^a   Trudell, James R ^b   Hyunh, Nhat ^a   Louie, Stan G ^a   Petasis, Nicos A ^a   Alkana, Ronald L ^a   Davies, Daryl L ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b STANFORD UNIVERSITY   (United States)

Author keywords

Alcoholism therapy; Ivermectin; Medications development

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; ABAMECTIN; ALCOHOL; AVERMECTIN; LIGAND GATED ION CHANNEL; PURINERGIC P2X4 RECEPTOR; SELAMECTIN; AMINO ACID RECEPTOR STIMULATING AGENT; CENTRAL DEPRESSANT AGENT; IVERMECTIN;

ADDICTION; ALCOHOL CONSUMPTION; ALCOHOL USE DISORDER; ALCOHOLISM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG PENETRATION; DRUG RECEPTOR BINDING; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STRUCTURE ACTIVITY RELATION; XENOPUS; ALCOHOL-RELATED DISORDERS; ANALOGS AND DERIVATIVES; ANIMAL; BRAIN; C57BL MOUSE; CHEMISTRY; COMPARATIVE STUDY; DRINKING BEHAVIOR; DRUG EFFECTS; DRUG THERAPY; GENETICS; METABOLISM; PATHOPHYSIOLOGY;

ALCOHOL DRINKING; ALCOHOL-RELATED DISORDERS; ANIMALS; BRAIN; CENTRAL NERVOUS SYSTEM DEPRESSANTS; ETHANOL; EXCITATORY AMINO ACID AGONISTS; IVERMECTIN; MALE; MICE, INBRED C57BL; RECEPTORS, GABA-A; RECEPTORS, PURINERGIC P2X4; XENOPUS;

EID: 84899759559     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145713001703     Document Type: Article

References (34)

1. Asatryan L, Popova M, Perkins DI, Trudell JR, Alkana RL, Davies DL. (2010) Ivermectin antagonizes ethanol inhibition in P2X4 receptors. J Pharmacol Exp Ther 334:720-728.
2. Bortolato M, Yardley M, Khoja S, Godar SC, Asatryan L, Finn DA, Alkana RL, Louie SG, Davies DL. (2013) Pharmacological insights into the role of P2X4 receptors in behavioral regulation: Lessons from ivermectin. Int J Neuropsychopharmacol 16:1059-1070.
3. Bouchery EE, Harwood HJ, Sacks JJ, Simon CJ, Brewer RD. (2011) Economic costs of excessive alcohol consumption in the U.S., 2006. Am J Prevent Med 41:516-524.
4. Colombo G, Orr A, Lai P, Cabras C, Maccioni P, Rubio M, Gessa GL, Carai MA. (2007) The cannabinoid CB1 receptor antagonist, rimonabant, as a promising pharmacotherapy for alcohol dependence: Preclinical evidence. Mol Neurobiol 36:102-112.
5. Crump A, Omura S. (2011) Ivermectin, 'wonder drug' from Japan: The human use perspective. Proc Jpn Acad Ser B Phys Biol Sci 87:13-28.
6. Cully DF, Vassilatis DK, Liu KK, Paress PS, Van der Ploeg LHT, Schaeffer JM, Arena JP. (1994) Cloning of an avermectinsensitive glutamate-gated chloride channel from Caenorhabditis elegans. Nat 371:707-711.
7. Davies DL, Machu TK, Guo Y, Alkana RL. (2002) Ethanol sensitivity in ATP-gated P2X receptors is subunit dependent. Alcohol Clin Exp Res 26:773-778.
8. Davies DL, Kochegarov AA, Kuo ST, Kulkarni AA, Woodward JJ, King BF, Alkana RL. (2005) Ethanol differentially affects ATP-gated P2X(3) and P2X(4) receptor subtypes expressed in Xenopus oocytes. Neuropharmacol 49:243-253.
9. Dawson GR, Wafford KA, Smith A, Marshall GR, Bayley PJ, Schaeffer JM, Meinke PT, McKernan RM. (2000) Anticonvulsant and adverse effects of avermectin analogs in mice are mediated through the gamma-Aminobutyric acid A receptor. J Pharmacol Exp Ther 295:1051-1060.
10. Dent JA, Davis MW, Avery L. (1997) avr-15 encodes a chloride channel subunit that mediates inhibitory glutamatergic neurotransmission and ivermectin sensitivity in Caenorhabditis elegans. EMBO J 16:5867-5879.
11. Gewiss M, Heidbreder C, Opsomer L, Durbin P, De Witte P. (1991) Acamprosate and diazepam differentially modulate alcohol-induced behavioural and cortical alterations in rats following chronic inhalation of ethanol vapour. Alcohol Alcohol 26:129-137.
12. Grant BF, Dawson DA, Stinson FS, Chou P, Dufour MC, Pickering RP. (2004) The 12-month prevalence and trends in DSM-IV alcohol abuse and dependence: United States, 1991-1992 and 2001-2002. Drug Alcohol Depend 74:223-234.
13. Halley BA, Narasimhan NI, Venkataraman K, Taub R, Erwin MLG, Andrew NW, Wislocki PG. (1992) Ivermectin and abamectin metabolism: Differences and similarities. Washington, DC: American Chemical Society, Vol. 503, pp 203-216.
14. Harris AH, Kivlahan DR, Bowe T, Humphreys KN. (2010) Pharmacotherapy of alcohol use disorders in the Veterans Health Administration. Psychiatr Serv 61:392-398.
15. Johnson B. (2010) Medication treatment of different types of alcoholism. Am J Psychiatry 167:630-639.
16. Johnson BA. (2008) Update on neuropharmacological treatments for alcoholism: Scientific basis and clinical findings. Biochem Pharmacol 75:34-56.
17. Khakh BS, Proctor WR, Dunwiddie TV, Labarca C, Lester HA. (1999) Allosteric control of gating and kinetics at P2X4 receptor channels. J Neurosci 19:7289-7299.
18. Krause RM, Buisson B, Bertrand S, Corringer PJ, Galzi JL, Changeux JP, Bertrand D. (1998) Ivermectin: A positive allosteric effector of the alpha 7 neuronal nicotinic acetylcholine receptor. Mol Pharmacol 53:283-294.
19. Krusek J, Zemkova H. (1994) Effect of ivermectin on gamma-Aminobutyric acid-induced chloride currents in mouse hippocampal embryonic neurones. Eur J Pharmacol 259:121-128.
20. Lespine A, Martin S, Dupuy J, Roulet A, Pineau T, Orlowski S, Alvinerie M. (2007) Interaction of macrocyclic lactones with P-glycoprotein: Structure-Affinity relationship. Eur J Pharm Sci 30:84-94.
21. Litten RZ, Egli M, Heilig M, Cui C, Fertig JB, Ryan ML, Falk DE, Moss H, Huebner R, Noronha A. (2012) Medications development to treat alcohol dependence: A vision for the next decade. Addict Biol 17:513-527.
22. Menez C, Sutra JF, Prichard R, Lespine A. (2012) Relative neurotoxicity of ivermectin and moxidectin in Mdr1ab. (-/-) mice and effects on mammalian GABA(A) channel activity. PLoS Negl Trop Dis 6:e1883.
23. Michael B, Meinke PT, Shoop W. (2001) Comparison of ivermectin, doramectin, selamectin, and eleven intermediates in a nematode larval development assay. J Parasitol 87:692-696.
24. Naimi TS. (2011) The cost of alcohol and its corresponding taxes in the U.S.: A massive public subsidy of excessive drinking and alcohol industries. Am J Prevent Med 41:546-547.
25. Omura S. (2008) Ivermectin: 25 years and still going strong. Int J Antimicrobial Agents 31:91-98.
26. Popova M, Trudell J, Li K, Alkana R, Davies D, Asatryan L. (2013) Tryptophan 46 is a site for ethanol and ivermectin action in P2X4 receptors. Purinergic Signal 4:621-632.
27. Priel A, Silberberg SD. (2004) Mechanism of ivermectin facilitation of human P2X4 receptor channels. J Gen Phys 123:281-293.
28. Sattelle DB, Buckingham SD, Akamatsu M, Matsuda K, Pienaar I, Jones AK, Sattelle BM, Almond A, Blundell CD. (2009) Comparative pharmacology and computational modelling yield insights into allosteric modulation of human alpha7 nicotinic acetylcholine receptors. Biochem Pharmacol 78:836-843.
29. Shan Q, Haddrill JL, Lynch JW. (2001) Ivermectin, an unconventional agonist of the glycine receptor chloride channel. J Biol Chem 276:12556-12564.
30. Spinosa HS, Stilck SRAN, Bernardi MM. (2002) Possible anxiolytic effects of ivermectin in rats. Vet Res Commun 26:309-321.
31. Steensland P, Simms JA, Holgate J, Richards JK, Bartlett SE. (2007) Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, selectively decreases ethanol consumption and seeking. Proc Natl Acad Sci USA 104:12518-12523.
32. Sung YF, Huang CT, Fan CK, Lin CH, Lin SP. (2009) Avermectin intoxication with coma, myoclonus, and polyneuropathy. Clin Toxicol 47:686-688.
33. Vassilatis DK, Arena JP, Plasterk RH, Wilkinson HA, Schaeffer JM, Cully DF, Van de Ploeg LH. (1997) Genetic and biochemical evidence for a novel avermectin-sensitive chloride channel in Caenorhabditis elegans: Isolation and characterization. J Biol Chem 272:33167-33174.
34. Yardley M, Wyatt L, Khoja S, Asatryan L, Ramaker MJ, Finn DA, Alkana RL, Huynh N, Louie SG, Petasis NA, Bortolato M, Davies DL. (2012) Ivermectin reduces alcohol intake and preference in mice. Neuropharmacol 63:190-201.